Business Description
![Rezolute Inc Rezolute Inc logo](https://static.gurufocus.com/logos/0C000096L4.png?14)
Rezolute Inc
NAICS : 325412
SIC : 2834
ISIN : US76200L1017
Description
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 33.75 | |||||
Equity-to-Asset | 0.81 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.04 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 34.1 | |||||
3-Year EPS without NRI Growth Rate | 34.2 | |||||
3-Year FCF Growth Rate | 40.8 | |||||
3-Year Book Growth Rate | 36 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 45.01 | |||||
9-Day RSI | 47.37 | |||||
14-Day RSI | 50.17 | |||||
6-1 Month Momentum % | 504.64 | |||||
12-1 Month Momentum % | 179.04 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 11.82 | |||||
Quick Ratio | 11.82 | |||||
Cash Ratio | 11.5 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -84.5 | |||||
Shareholder Yield % | -0.53 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -57.11 | |||||
ROA % | -51.9 | |||||
ROIC % | -395.44 | |||||
ROC (Joel Greenblatt) % | -2621.15 | |||||
ROCE % | -54.21 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 2.34 | |||||
Price-to-Tangible-Book | 2.34 | |||||
EV-to-EBIT | -2.47 | |||||
EV-to-Forward-EBIT | -2.79 | |||||
EV-to-EBITDA | -2.48 | |||||
EV-to-Forward-Revenue | 0.1 | |||||
EV-to-FCF | -2.83 | |||||
Price-to-Net-Current-Asset-Value | 2.53 | |||||
Price-to-Net-Cash | 2.62 | |||||
Earnings Yield (Greenblatt) % | -40.49 | |||||
FCF Yield % | -22.86 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:RZLT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Rezolute Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -1.14 | ||
Beta | 0.23 | ||
Volatility % | 101.98 | ||
14-Day RSI | 50.17 | ||
14-Day ATR ($) | 0.376893 | ||
20-Day SMA ($) | 4.4695 | ||
12-1 Month Momentum % | 179.04 | ||
52-Week Range ($) | 0.72 - 6.0999 | ||
Shares Outstanding (Mil) | 53.17 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Rezolute Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Rezolute Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Rezolute Inc Frequently Asked Questions
What is Rezolute Inc(RZLT)'s stock price today?
The current price of RZLT is $4.13. The 52 week high of RZLT is $6.10 and 52 week low is $0.72.
When is next earnings date of Rezolute Inc(RZLT)?
The next earnings date of Rezolute Inc(RZLT) is 2024-09-13 Est..
Does Rezolute Inc(RZLT) pay dividends? If so, how much?
Rezolute Inc(RZLT) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |